Alembic Pharma gains 0.92% on USFDA nod for Sacubitril and Valsartan tablets

This approval encompasses tablets containing 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg of the medication

Subscribe To Our Free Newsletter